Urology Practice Database

The urology market is characterized by high-cost procedures, significant technology adoption, and an aging patient population driving sustained demand. Robotic surgery has transformed the specialty, with over 90% of prostatectomies now performed robotically, making urologists key customers for surgical robotics and related instrumentation.

Market Overview

The US urology market generates approximately $22 billion annually with strong growth driven by demographic trends and technology adoption. The total addressable market for vendors includes:

• Robotic surgery systems and instruments: $3 billion (da Vinci systems dominate)
• Urology pharmaceuticals: $8 billion (BPH medications, overactive bladder drugs, oncology agents)
• Lithotripsy and stone management equipment: $1.5 billion
• Implantable devices: $1 billion (penile prostheses, artificial sphincters, neuromodulation)
• Endoscopy equipment and disposables: $2 billion
• Diagnostics and imaging: $1.5 billion

Private equity has shown strong interest in urology, acquiring practices and building platforms that consolidate purchasing and create enterprise sales opportunities.

Practice Landscape

• Practice Types:
• **Large single-specialty groups (35%)** - 5-30+ urologists, often with multiple locations, ASC ownership, and robotic surgery programs
• **Hospital-employed practices (35%)** - Integrated into health systems, access to hospital robotic platforms, decisions influenced by system procurement
• **Small groups and solo practitioners (25%)** - 1-4 physicians, may refer complex robotic cases, focus on office-based procedures
• **Academic medical centers (5%)** - Teaching institutions with full subspecialty coverage, research programs, early technology adopters

• Ownership Models:
• Strong physician ownership tradition, though declining with PE consolidation
• Many practices own or partner in ambulatory surgery centers
• Robotic surgery often performed at hospital partners due to capital requirements
• Growing MSO (management services organization) presence

• Geographic Distribution:
• Practices concentrated in metropolitan areas with aging populations
• Highest density in Florida, Arizona, California, Texas, and the Northeast
• Rural access gaps create telemedicine and mobile service opportunities
• Retirement communities represent high-density patient populations

Key Decision Makers

• Physician Leadership:
• Managing partners control strategic direction and major purchases
• Robotic surgeons influence surgical technology decisions
• Subspecialists (oncology, female pelvic medicine, pediatrics) drive niche product adoption
• Individual physicians specify implants and disposables

• Administrative Leadership:
• Practice administrators manage vendor relationships and negotiate contracts
• ASC directors oversee surgical facility operations and supplies
• Revenue cycle managers evaluate billing software and services
• Purchasing managers handle supply chain and inventory

• Clinical Staff:
• Surgical coordinators influence workflow and equipment preferences
• Medical assistants and nurses affect office supply decisions
• Ultrasonographers and imaging techs influence diagnostic equipment

What's In Our Database

Our urology practice database provides comprehensive data for targeted sales and marketing campaigns:

• Practice Information:
• Practice name, address, phone, fax
• Website and email contacts
• Number of physicians and office locations
• ASC ownership and hospital affiliations
• Health system relationships

• Provider Details:
• Urologist names and credentials
• NPI numbers
• Subspecialty training (oncology, female pelvic, pediatric, endourology, male infertility)
• Medical school and residency/fellowship training
• Years in practice and estimated procedure volumes

• Technology Profile:
• Robotic surgery capability and platform (da Vinci model)
• Lithotripsy equipment (in-office vs. mobile service)
• EHR and practice management systems
• Imaging and diagnostic equipment

• Operational Data:
• Estimated surgical and office procedure volumes
• Payer mix indicators
• Accreditation and quality certifications

Use Cases

• Medical Device Sales:
• Target high-volume robotic surgery practices for instrument and accessory sales
• Identify practices performing stone procedures for lithotripsy equipment
• Reach urologists placing implants (penile prostheses, artificial sphincters, slings)
• Segment by subspecialty for focused product launches

• Pharmaceutical Marketing:
• Target prescribers of BPH medications (alpha blockers, 5-alpha reductase inhibitors)
• Reach urologic oncologists for prostate and bladder cancer drugs
• Identify practices managing overactive bladder for OAB drug promotion
• Target testosterone prescribers for hypogonadism treatments

• Capital Equipment:
• Market robotic systems and upgrades to practices seeking programs
• Sell laser systems for BPH treatment (HoLEP, Greenlight) and lithotripsy
• Target practices for in-office imaging and diagnostic equipment
• Reach ASCs for surgical equipment and facility upgrades

• Healthcare Services:
• Revenue cycle management for complex surgical billing
• Pathology laboratory services for prostate and bladder biopsies
• Recruiting services for urology physician shortages
• Telemedicine platforms for follow-up care

• Market Research:
• Track robotic surgery adoption and competitive landscape
• Survey urologists for product development and positioning
• Analyze consolidation trends and PE investment activity
• Monitor new technology adoption patterns

Industry Statistics

Market Size - $22 billion annually in the US Number of Practices - ~9,000 urology practices Active Surgeons - ~13,500 urologists in the US Prostate Cancer Surgeries - 85,000 annually Stone Procedures - 500,000+ annually Robotic Procedures - 250,000+ annually Average Major Case Value - $8,000-$30,000 Prostate Cancer Incidence - 290,000 new cases diagnosed annually Kidney Stone Prevalence - 1 in 10 Americans will have a kidney stone BPH Prevalence - 50% of men over 50 have symptoms Robotic Surgery Adoption - 90%+ of prostatectomies are robotic

Why Target Urology Practices

High Technology Adoption - Urologists are among the highest adopters of robotic surgery and minimally invasive technology, driving demand for advanced equipment and instrumentation.

Capital Equipment Buyers - Practices invest heavily in lasers, lithotripters, robotic instruments, and diagnostic equipment, creating significant capital sales opportunities.

Implant Specialists - Urologists place high-margin implantable devices including penile prostheses, artificial urinary sphincters, and neuromodulation systems.

Pharmaceutical Volume - High prescribing volume for chronic conditions (BPH, OAB, testosterone) creates sustained pharmaceutical sales opportunities.

Aging Demographics - The 65+ population is the fastest growing demographic, driving increased demand for prostate, bladder, and kidney stone services.

Procedure Diversity - Mix of office procedures (cystoscopy, biopsies, vasectomy), ASC cases (stone surgery), and hospital cases (robotic surgery) creates multiple sales entry points.

Consolidation Opportunity - PE investment in urology creates opportunities for enterprise sales to growing practice platforms.

Frequently Asked Questions